Allison T G, Squires R W, Johnson B D, Gau G T
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic Rochester, Minnesota 55905, USA.
Mayo Clin Proc. 1999 May;74(5):466-73. doi: 10.4065/74.5.466.
To determine how frequently the National Cholesterol Education Program (NCEP) goal of a low-density lipoprotein (LDL) cholesterol level of 100 mg/dL or less is achieved in clinical practice in patients with coronary artery disease and what fraction of patients can achieve this goal without drug therapy.
We examined the results of lipid management in 152 consecutive patients who had completed cardiac rehabilitation after an acute coronary event. Patients were randomized to follow-up by specially trained nurses or by preventive cardiologists, and they were not receiving lipid-lowering drugs at the start of the study.
Patients were given aggressive diet and exercise recommendations and lipid-lowering drugs in accordance with NCEP guidelines. Follow-up was continued for a mean of 526 days after the first lipid assessment subsequent to the coronary event. Multiple logistic regression analysis was used to identify independent predictors of a final LDL cholesterol level of 100 mg/dL or less.
Of the study group, 39% achieved the NCEP goal LDL cholesterol level of 100 mg/dL or less. Characteristics of the patients with LDL cholesterol levels of 100 mg/dL or less in comparison with those with LDL cholesterol levels of more than 100 mg/dL included a greater frequency of drug therapy (65% versus 38%), more rigorous dietary compliance, longer follow-up (586 +/- 317 days versus 493 +/- 264 days), more favorable weight change (-0.3 +/- 4.9 kg versus +1.7 +/- 5.0 kg), and more extensive weekly exercise (183 +/- 118 minutes versus 127 +/- 107 minutes).
The registered nurses managed the lipids of these patients as effectively as did the preventive cardiologists. Appropriate drug therapy was the most important factor in achieving an LDL cholesterol level of 100 mg/dL or less, but 35% of patients attaining this NCEP goal were not receiving drug therapy. Exercise, dietary compliance, and weight loss were also important factors.
确定在冠心病患者的临床实践中,达到美国国家胆固醇教育计划(NCEP)设定的低密度脂蛋白(LDL)胆固醇水平为100mg/dL或更低这一目标的频率,以及无需药物治疗就能达到该目标的患者比例。
我们检查了152例急性冠状动脉事件后完成心脏康复的连续患者的血脂管理结果。患者被随机分配由经过专门培训的护士或预防心脏病专家进行随访,且在研究开始时未接受降脂药物治疗。
根据NCEP指南,为患者提供积极的饮食和运动建议以及降脂药物。在冠状动脉事件后的首次血脂评估后,平均持续随访526天。采用多因素逻辑回归分析来确定最终LDL胆固醇水平为100mg/dL或更低的独立预测因素。
在研究组中,39%的患者达到了NCEP设定的LDL胆固醇水平目标,即100mg/dL或更低。与LDL胆固醇水平高于100mg/dL的患者相比,LDL胆固醇水平为100mg/dL或更低的患者的特征包括:药物治疗频率更高(65%对38%)、饮食依从性更严格、随访时间更长(586±317天对493±264天)、体重变化更有利(-0.3±4.9kg对+1.7±5.0kg)以及每周运动量更大(183±118分钟对127±107分钟)。
注册护士对这些患者血脂的管理效果与预防心脏病专家相当。适当的药物治疗是使LDL胆固醇水平达到100mg/dL或更低的最重要因素,但达到这一NCEP目标的患者中有35%未接受药物治疗。运动、饮食依从性和体重减轻也是重要因素。